Statistics

Total Visits

Views
Compound mutations in BCR-ABL1 are not major drivers of primary or secondary resistance to ponatinib in CP-CML patients 42

Total Visits per Month

June 2019 July 2019 August 2019 September 2019 October 2019 November 2019 December 2019
Compound mutations in BCR-ABL1 are not major drivers of primary or secondary resistance to ponatinib in CP-CML patients 6 0 0 0 3 4 1

File Downloads

Views

Top Country Views

Views
Australia 17
United States 16
France 6
China 1
Germany 1
Russia 1

Top City Views

Views
Kaleen 17
Ashburn 7
Fairfield 5
Perm 1
Wuhan 1